<DOC>
	<DOCNO>NCT01755182</DOCNO>
	<brief_summary>The purpose study verify add locoregional treatment liver metastasis ( trans-arterial embolization-TAE ) medical treatment prove efficacy prolong progression free survival patient affect neuroendocrine tumor ( NET ) inoperable liver metastasis</brief_summary>
	<brief_title>Systemic Therapy With Without Upfront Transarterial Embolization Inoperable Liver Metastasis Neuroendocrine Tumors</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Somatostatin</mesh_term>
	<criteria>Diagnosis NET gastroenteropancreatic ( GEP ) , pulmonary unknown primary site origin Unresectable liver metastasis , accord judgment surgeon , ( reason opinion surgeon make explicit ) Hepatic involvement ≤50 % volume organ Radiological evidence hepatic lesion ( contemporaneous progression appearance extrahepatic lesion allow critical site ) require change initiation systemic pharmacotherapy Patients undergoing , previously treat , never treat systemic medical therapy eligible Patients without carcinoid syndrome eligible Well ( G1 ) medium ( G2 ) differentiate histology ( accord WHO 2010 classification ) Ki67 ≤ 20 % ( G1G2 ) Life expectancy &gt; 6 month Age ≥ 18 &lt; 80 year Previous locoregional postsurgical treatment Poorly differentiate histology Severe concomitant morbidity : severe coagulopathy , severe liver failure ( detail ) , renal failure ( creatinine &gt; 2.0 mg/dl ) heart failure ( NYHA 34 unstable ischemic heart disease ) , contraindicate interventional procedure influence general prognosis ( Investigator provide detail exclusion ) Extrahepatic metastasis critical location : brain , spinal cord , lung respiratory impairment , symptomatic vertebral lesion Patients extrahepatic lesion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>locoregional treatment</keyword>
	<keyword>liver metastasis</keyword>
	<keyword>transarterial embolization</keyword>
	<keyword>upfront treatment</keyword>
	<keyword>inoperable</keyword>
	<keyword>octreotide</keyword>
	<keyword>gastroenteropancreatic ( GEP ) primary</keyword>
	<keyword>pulmonary primary</keyword>
	<keyword>primary unknown origin</keyword>
	<keyword>systemic therapy</keyword>
</DOC>